Randomized Control Clinical Trial for Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension (KRGCBP)

NCT02211352 Phase 2 COMPLETED

The purpose of this study is to determine Korean red ginseng (KRG)treatment could decrease central blood pressure in subjects with hypertension.

Details

Lead sponsor	Daegu Catholic University Medical Center
Phase	Phase 2
Status	COMPLETED
Enrolment	58
Start date	2012-05
Completion	2014-07

Conditions

• Hypertension

Interventions

• Korean Red Ginseng Capsules
• Placebo

Primary outcomes

• central blood pressure change after treatment of Korea Red Ginseng — baseline, 8 weeks and 16 weeks after treatment

Countries

South Korea